GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (FRA:TRB) » Definitions » E10

Trinity Biotech (FRA:TRB) E10 : €-6.07 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Trinity Biotech E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Trinity Biotech's adjusted earnings per share data for the three months ended in Dec. 2023 was €-13.168. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-6.07 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was -32.40% per year. During the past 5 years, the average E10 Growth Rate was -69.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Trinity Biotech was 190.80% per year. The lowest was -109.60% per year. And the median was -22.50% per year.

As of today (2024-05-14), Trinity Biotech's current stock price is €2.12. Trinity Biotech's E10 for the quarter that ended in Dec. 2023 was €-6.07. Trinity Biotech's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Trinity Biotech was 84.24. The lowest was 30.33. And the median was 62.36.


Trinity Biotech E10 Historical Data

The historical data trend for Trinity Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trinity Biotech E10 Chart

Trinity Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.25 -2.42 -3.11 -4.51 -6.07

Trinity Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.51 -4.51 -4.89 -5.09 -6.07

Competitive Comparison of Trinity Biotech's E10

For the Diagnostics & Research subindustry, Trinity Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trinity Biotech's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Trinity Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Trinity Biotech's Shiller PE Ratio falls into.



Trinity Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Trinity Biotech's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-13.168/120.1096*120.1096
=-13.168

Current CPI (Dec. 2023) = 120.1096.

Trinity Biotech Quarterly Data

per share eps CPI Adj_EPS
201403 0.658 100.573 0.786
201406 0.670 100.773 0.799
201409 0.714 100.474 0.854
201412 0.714 99.576 0.861
201503 0.785 99.975 0.943
201506 0.441 100.573 0.527
201509 0.432 100.274 0.517
201512 0.482 99.676 0.581
201603 -0.260 99.676 -0.313
201606 0.378 101.072 0.449
201609 -0.102 100.274 -0.122
201612 -21.003 99.676 -25.309
201703 0.234 100.374 0.280
201706 0.182 100.673 0.217
201709 0.088 100.474 0.105
201712 -8.573 100.075 -10.289
201803 0.073 100.573 0.087
201806 0.120 101.072 0.143
201809 0.184 101.371 0.218
201812 -5.037 100.773 -6.004
201903 -0.044 101.670 -0.052
201906 -1.146 102.168 -1.347
201909 0.004 102.268 0.005
201912 -5.040 102.068 -5.931
202003 -0.481 102.367 -0.564
202006 -0.311 101.769 -0.367
202009 1.189 101.072 1.413
202012 -1.973 101.072 -2.345
202103 0.298 102.367 0.350
202106 -0.156 103.364 -0.181
202109 0.259 104.859 0.297
202112 -0.266 106.653 -0.300
202203 -2.270 109.245 -2.496
202206 -1.343 112.734 -1.431
202209 -1.187 113.431 -1.257
202212 -1.251 115.425 -1.302
202303 -0.710 117.618 -0.725
202306 -0.720 119.611 -0.723
202309 -0.820 120.708 -0.816
202312 -13.168 120.110 -13.168

Add all the adjusted EPS together and divide 10 will get our e10.


Trinity Biotech  (FRA:TRB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Trinity Biotech was 84.24. The lowest was 30.33. And the median was 62.36.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Trinity Biotech E10 Related Terms

Thank you for viewing the detailed overview of Trinity Biotech's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Trinity Biotech (FRA:TRB) Business Description

Traded in Other Exchanges
Address
IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.

Trinity Biotech (FRA:TRB) Headlines

No Headlines